Novotech to acquire Agilex Biolabs
Deal adds bioanalytical expertise in Australia
Read More
Author: John Pinching
Nezglyal approved in EU for childhood cALD
First pharmacological option for early intervention
Read More
NICE backs first systemic therapy for desmoid tumours
Approval gives patients access to new targeted option
Read More
AbbVie wins EU approval for paediatric pJIA use
New indication adds oral option for young patients
Read More
Investor horizons ahead of CPHI 2026
Key CDMO trends shaping strategies in a shifting global market
Read More
